BREAKING NEWS
New Delhi: In the breaking development, The Expert Panel of the Drug Regulatory Authority (DPA) regarding the Covid vaccine will review the application of Serum Institute of India today. Serum Institute had sought approval for emergency use of Covovax to children aged two to seven years and seven to 11
New Delhi: Serum Institute of India (SII) CEO Adar Poonawalla on Saturday announced that clinical trials of Covid-19 vaccine Covovax have started in India and that the company plans to launch it by September this year. In August 2020, American vaccine company Novavax Inc, had announced a license agreement with
